Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways

International Archives of Allergy and Immunology

Volumn 138, Issue 1, 2005, Pages 80-87

  Yoshihara, Shigemi ^a   Morimoto, Hiroshi ^b   Ohori, Makoto ^b   Yamada, Yumi ^a   Abe, Toshio ^a   Arisaka, Osamu ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Airway; C fibers; Cannabinoid; Guinea pig; Maxi K+ channels

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CHARYBDOTOXIN; DENDROTOXIN; GLIBENCLAMIDE; IBERIOTOXIN; NEUROKININ A; PALMIDROL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; RIMONABANT; SUBSTANCE P;

AGONIST; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; BRONCHUS MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC FIELD; ELECTROSTIMULATION; GUINEA PIG; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SMOOTH MUSCLE CONTRACTILITY;

ANIMALS; ARACHIDONIC ACIDS; BORNANES; BRONCHI; BRONCHOCONSTRICTION; CALCIUM CHANNEL BLOCKERS; CAPSAICIN; ELECTRIC STIMULATION; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NERVE FIBERS, UNMYELINATED; NEUROGENIC INFLAMMATION; ORGAN CULTURE TECHNIQUES; PALMITIC ACIDS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; POTASSIUM CHANNEL BLOCKERS; PYRAZOLES; RECEPTORS, CANNABINOID; SUBSTANCE P;

EID: 24744448386     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087361     Document Type: Article

References (43)

1. Barnes PJ: Neuroeffector mechanisms: the interface between inflammation and neuronal responses. J Allergy Clin Immunol 1996;98:S73-S83.
2. Joos GF, Pauwels RA: Tachykinin receptor antagonists: potential in airways diseases. Curr Opin Pharmacol 2001;1:235-241.
3. Murai M, Morimoto H, Maeda Y, Fujii T: Effects of the tripeptide substance P antagonist, FR 113680, on airway constriction and airway edema induced by neurokinins in guinea-pigs. Eur J Pharmacol 1992a;217:23-27.
4. Murai M, Morimoto H, Maeda Y, Kiyotoh S, Nishikawa M, Fujii T: Effects of FK 224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea-pigs. J Pharmacol Exp Ther 1992b;262:403-408.
5. Morimoto H, Yamashita M, Matsuda A, Miyake H, Fujii T: Effects of FR 113680 and FK 224, novel tachykinin antagonists, on cigarette smoke-induced rat tracheal plasma extravasation. Eur J Pharmacol 1992;224:1-5.
6. Yoshihara S, Chan B, Yamawaki I, Pierangelo G, Ricciardolo FLM, Massion PP, Nadel JA: Plasma extravasation in the rat trachea induced by cold air is mediated by tachykinin release from sensory nerves. Am J Respir Crit Care Med 1995;151:1011-1017.
7. Ono M, Abe T, Watanabe M, Yamada Y, Yoshihara S: Nedocromil sodium inhibits hypertonic saline-induced plasma extravasation in guinea-pig airways. Biomed Res 1999;20:233-238.
8. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
9. Morimoto H, Matsuda A, Ohori M, Fujii T: Effects of ω-conotoxin GVIA on the activation of capsaicin-sensitive afferent sensory nerves in guinea pig airway tissues. Jpn J Pharmacol 1996;71:161-166.
10. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG: International union of pharmacology. 27. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202.
11. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of peripheral receptor for cannabinoids. Nature 1993;365:61-65.
12. Glass M, Dragunow M, Faull RL: Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997;77:299-318.
13. Griffin G, Fernando SR, Ross RA, Mckay NG, Ashford ML, Shire D, Huffman JW, Yu S, Lainton JA, Pertwee RG: Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 1997;339:53-61.
14. Howlett AC, Johnson MR, Melvin LS, Mine GM: Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol 1988;33:297-302.
15. Mackie KY, Westenbroek LR, Mitchell R: Cannabinoid activate an inwardly rectifying potassium conductance and inhibit Q-type cannabinoid receptor. J Neurosci 1995;15:6552-6561.
16. Caulfield MP, Brown DA: Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol 1992;106:231-232.
17. Mackie K, Hille B: Cannabinoid inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 1992;89:3825-3829.
18. Fox AJ, Barnes PJ, Venkatesan P, Belvisi MG: Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J Clin Invest 1997;99:513-519.
19. Ray NJ, Jones AJ, Keen P: Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br J Pharmacol 1991;102:797-800.
20. Wu P, Penman E, Coy DH, Rees LH: Evidence for direct production of somatostatin-14 from a larger precursor than somatostatin-28 in a phaeochromocytoma. Regul Pept 1983;5:219-233.
21. Mulkey RM, Zucker RS: Action potentials must admit calcium to evoke transmitter release. Nature 1991;350:153-155.
22. Saria A, Martling CR, Yan Z, Theodorsson-Norheim E, Gamse R, Lundberg JM: Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis 1988;137:1330-1335.
23. Franco-Cereceda A, Saria A, Lundberg JM: Differential release of calcitonin-gene related peptide and neuropeptide Y from the isolated heart by capsaicin, ischemia, nicotine, bradykinin and ouabain. Acta Physiol Scand 1989;135:173-187.
24. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-1949.
25. Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, Vogel Z: The peripheral cannabinoid receptor: adenylatecyclase inhibition and G protein coupling. FEBS Lett 1995;375:143-147.
26. Rinaldi-Carmona M, Calandra B, Shire D, Bouaboula M, Oustric D, Barth F, Casellas P, Ferrara P, Le Fur G: Characterization of two cloned human CB1 cannabinoid receptor isoforms. J Pharmacol Exp Ther 1996;278:871-878.
27. 35S]thio)-triphosphate binding assay in rat cerebellar membranes. J Pharmacol Exp Ther 1998;285:553-560.
28. Partwee RG: Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999;6:635-664.
29. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA: Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 1993;90:7656-7660.
30. Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 1993;61:352-355.
31. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 1995;92:3376-3380.
32. Tucker RC, Kagaya M, Page CP, Spina D: The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br J Pharmacol 2001;132:1127-1135.
33. Aloe L, Leon A, Levi-Montalcini R: A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 1993;39:C145-C147.
34. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A: N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996;300:227-236.
35. Abood ME, Martin BR: Molecular neurobiology of the cannabinoid receptor. Int Rev Neurobiol 1996;39:197-221.
36. Lambert DM, Di Marzo V: The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem 1999;6:757-773.
37. Calignano A, La Rana G, Piomelli D: Antinociceptive activity of the endogenous fatty acid amide, palmitoylethanolamide. Eur J Pharmacol 2001;419:191-198.
38. Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G: Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 2002;135:181-187.
39. Miura M, Inoue H, Ichinose M, Kimura K, Katsumata U, Takishima T: Effect of nonadrenergic noncholinergic inhibitory nerve stimulation on the allergic reaction in cat airways. Am Rev Respir Dis 1990;141:29-32.
40. Miura M, Ichinose M, Kimura K, Katsumata U, Takahashi T, Inoue H, Takishima T: Dysfunction of nonadrenergic noncholinergic inhibitory system after antigen inhalation in actively sensitized cat airways. Am Rev Respir Dis 1992;145:70-74.
41. Friedman MM, Kaliner MA: Human mast cells and asthma. Am Rev Respir Dis 1987;135:1157-1164.
42. Cook SA, Welch SP, Lichtman H, Martin BR: Evaluation of cAMP involvement in cannabinoid-induced antinociception. Life Sci 1995;56:2049-2056.
43. Holzer P: Local effector function of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-768.